These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3491877

  • 1. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
    Gredal O, Nielsen M.
    J Neurochem; 1987 Feb; 48(2):370-5. PubMed ID: 3491877
    [Abstract] [Full Text] [Related]

  • 2. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O, Nielsen M, Hyttel J.
    Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
    [Abstract] [Full Text] [Related]

  • 3. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 4. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
    Zhang X, Segawa T.
    Jpn J Pharmacol; 1989 Jul 07; 50(3):333-45. PubMed ID: 2569545
    [Abstract] [Full Text] [Related]

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 07; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 6. In situ molecular size of agonist dopamine D-2 binding sites in rat striatum.
    Gredal O, Nielsen M.
    J Neurochem; 1987 Feb 07; 48(2):364-9. PubMed ID: 3794711
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum.
    Cincotta M, de Vries DJ, Beart PM.
    Neurosci Lett; 1985 Oct 24; 61(1-2):85-9. PubMed ID: 2867505
    [Abstract] [Full Text] [Related]

  • 8. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.
    Dubois A, Savasta M, Curet O, Scatton B.
    Neuroscience; 1986 Sep 24; 19(1):125-37. PubMed ID: 2946980
    [Abstract] [Full Text] [Related]

  • 9. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE, Gessner GW, Crooke ST, Heys JR, Weinstock J.
    Life Sci; 1986 Jun 09; 38(23):2087-96. PubMed ID: 2872567
    [Abstract] [Full Text] [Related]

  • 10. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK, Ross GM, Bajwa SB, Mishra RK.
    Neurochem Res; 1990 Jun 09; 15(6):647-57. PubMed ID: 1977093
    [Abstract] [Full Text] [Related]

  • 11. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X, Segawa T.
    Eur J Pharmacol; 1989 Aug 03; 166(3):401-10. PubMed ID: 2680521
    [Abstract] [Full Text] [Related]

  • 12. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM, Waddington JL.
    Neuropharmacology; 1992 Feb 03; 31(2):177-83. PubMed ID: 1532443
    [Abstract] [Full Text] [Related]

  • 13. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G, Arnt J, Hyttel J.
    Eur J Pharmacol; 1988 Aug 24; 153(2-3):309-11. PubMed ID: 3053212
    [Abstract] [Full Text] [Related]

  • 14. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the central and renal dopamine-1 receptor.
    Sidhu A, Felder RA, Jose PA, Fishman PH.
    Am J Hypertens; 1990 Jun 07; 3(6 Pt 2):37S-39S. PubMed ID: 1974441
    [Abstract] [Full Text] [Related]

  • 16. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 17. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
    Plantjé JF, Daus FJ, Hansen HA, Stoof JC.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep 02; 327(2):180-2. PubMed ID: 6208489
    [Abstract] [Full Text] [Related]

  • 18. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT, Matsokis NA, Valcana T.
    J Neurosci Res; 1993 Aug 01; 35(5):499-506. PubMed ID: 8377223
    [Abstract] [Full Text] [Related]

  • 19. Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.
    Sibley DR, Leff SE, Creese I.
    Life Sci; 1982 Aug 16; 31(7):637-45. PubMed ID: 6127585
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A.
    Life Sci; 1984 Oct 29; 35(18):1885-93. PubMed ID: 6387355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.